Dean Capital Management Catalent, Inc. Transaction History
Dean Capital Management
- $172 Million
- Q1 2024
Shares
2 transactions
Others Institutions Holding CTLT
# of Institutions
485Shares Held
172MCall Options Held
865KPut Options Held
687K-
Vanguard Group Inc Valley Forge, PA20.4MShares$1.17 Billion0.02% of portfolio
-
Black Rock Inc. New York, NY15.2MShares$868 Million0.02% of portfolio
-
Capital World Investors Los Angeles, CA12.9MShares$738 Million0.12% of portfolio
-
Nomura Holdings Inc Tokyo, M011.3MShares$643 Million1.65% of portfolio
-
Janus Henderson Group PLC London, X09.56MShares$546 Million0.3% of portfolio
About Catalent, Inc.
- Ticker CTLT
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 179,896,000
- Market Cap $10.3B
- Description
- Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...